IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus

Rosanne Spolski1,2, Erin E West1,2, Peng Li1,2

  • 1Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, United States.

Elife
|April 11, 2019
PubMed

Insights

Interleukin-21 (IL-21) enhances host defense against Methicillin-resistant Staphylococcus aureus (MRSA) by promoting granzyme production. However, blocking IL-21 signaling unexpectedly boosts MRSA clearance via type I interferon.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses significant healthcare challenges.
  • Understanding host immune mechanisms against MRSA is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of Interleukin-21 (IL-21) in the innate immune response to MRSA pulmonary infections.
  • To elucidate the interplay between IL-21 and type I Interferon (IFN) signaling in MRSA clearance.

Main Methods:

  • Intra-tracheal administration of IL-21 in wild-type mice.
  • Assessment of MRSA clearance with neutrophil depletion and granzyme B inhibition.
  • Analysis of IL-21 receptor knockout (Il21r KO) mice and IL-21R-Fc fusion protein treatment.
  • Evaluation of type I IFN pathway activation and its impact on MRSA clearance.

Main Results:

  • IL-21 administration augmented pulmonary MRSA clearance in a granzyme-dependent manner, involving neutrophils.
  • Blocking IL-21 signaling paradoxically enhanced MRSA clearance, associated with increased type I IFN activity.
  • Type I IFN, specifically IFN-beta, induced granzyme B and promoted MRSA clearance independently.

Conclusions:

  • IL-21 plays a complex role in MRSA innate immunity, promoting clearance through granzymes.
  • Type I IFN signaling provides an alternative pathway for MRSA clearance, potentially compensating for IL-21 pathway modulation.
  • An intricate interplay exists between IL-21 and type I IFN in controlling MRSA infections.

Related Concept Videos

Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.8K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
83.5K
Introduction to Innate and Adaptive Immunity01:21

Introduction to Innate and Adaptive Immunity

The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
9.2K
What is the Immune System?01:38

What is the Immune System?

Overview
127.3K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.0K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
83.6K